0 149

Cited 1 times in

Predictors of analgesic efficacy of neurolytic celiac plexus block in patients with unresectable pancreatic cancer: the importance of timing

Authors
 Duck Mi Yoon  ;  Kyung Bong Yoon  ;  In Chan Baek  ;  Seo Hee Ko  ;  Shin Hyung Kim 
Citation
 SUPPORTIVE CARE IN CANCER, Vol.26(6) : 2023-2030, 2018 
Journal Title
 SUPPORTIVE CARE IN CANCER 
ISSN
 0941-4355 
Issue Date
2018
Keywords
Cancer pain ; Celiac plexus block ; Efficacy ; Pancreatic cancer
Abstract
BACKGROUND: Neurolytic celiac plexus block (NCPB) is a safe and effective method for reducing abdominal cancer pain. However, the analgesic efficacy of NCPB is not always guaranteed. The aim of this retrospective study was to identify predictors for the analgesic efficacy of NCPB in patients with unresectable pancreatic cancer. METHODS: Patients with unresectable pancreatic cancer who underwent NCPB from 2006 to 2015 were enrolled. Good analgesia after NCPB was defined as ≥ 50% reduction in pain score at day 30. Patient demographics, cancer characteristics, and pain-related factors were evaluated using a logistic regression analysis to identify predictors for good analgesia after NCPB. Additionally, survival outcomes were compared between patients with poor and good analgesia after NCPB. RESULTS: A total of 112 patients satisfied the study protocol requirements. Forty-seven patients (41.9%) showed good analgesia after NCPB. Better performance status, lower serum CA 19-9 level, shorter pain duration, and lower opioid dose were observed in patients with good analgesia after NCPB. Good performance status (ECOG performance status 1 vs. 2 or 3, OR = 2.737, 95% CI = 1.149 to 6.518, P = 0.023) and low daily opioid use (< 150 vs. ≥ 150 mg, OR = 2.813, 95% CI = 1.159 to 6.831, P = 0.022) before NCPB were independent predictors of good analgesia after NCPB. The median survival was significantly lower for patients with poor analgesia after NCPB (68 vs. 150 days, P < 0.001). CONCLUSION: NCPB should be offered early to selected patients to improve its analgesic efficacy in advance of deterioration from disease and pain in this population.
Full Text
https://link.springer.com/article/10.1007%2Fs00520-018-4043-2
DOI
10.1007/s00520-018-4043-2
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) > 1. Journal Papers
Yonsei Authors
Ko, Seo Hee(고서희) ORCID logo https://orcid.org/0000-0001-8402-5624
Kim, Shin Hyung(김신형) ORCID logo https://orcid.org/0000-0003-4058-7697
Baek, In Chan(백인찬) ORCID logo https://orcid.org/0000-0002-9497-3449
Yoon, Kyoung Bong(윤경봉) ORCID logo https://orcid.org/0000-0002-4167-1375
Yoon, Duck Mi(윤덕미)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/163826
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse